(Q35544756)

8 August 2017

title

Effects of silybum marianum on patients with chronic hepatitis C. (English)

1 reference

8 August 2017

1 reference

silybum marianum

1 reference

Hamid Kalantari

1

1 reference

8 August 2017

Zahra Shahshahan

2

1 reference

8 August 2017

Sayed Mehdi Hejazi

3

1 reference

8 August 2017

Taghi Ghafghazi

4

1 reference

8 August 2017

Vahid Sebghatolahi

5

1 reference

8 August 2017

publication date

1 March 2011

1 reference

Journal of Research in Medical Sciences

8 August 2017

published in

1 reference

8 August 2017

volume

16

1 reference

8 August 2017

issue

3

1 reference

8 August 2017

page(s)

287-290

1 reference

Efficacy of interferon alpha-2b with or without ribavirin in thalassemia major patients with chronic hepatitis C virus infection: A randomized, double blind, controlled, parallel group trial

8 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3214335

Multiple effects of silymarin on the hepatitis C virus lifecycle

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3214335

Silymarin treatment of viral hepatitis: a systematic review

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3214335

Randomised double-blinded trial evaluating silymarin for chronic hepatitis C in an Egyptian village: study description and 12-month results

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3214335

Effects of Silybum marianum on serum hepatitis C virus RNA, alanine aminotransferase levels and well-being in patients with chronic hepatitis C.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3214335

The Short Form Health Survey (SF-36): translation and validation study of the Iranian version

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3214335

Diagnosing fibrosis in hepatitis C: Is the pendulum swinging from biopsy to blood tests?

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3214335

An adverse reaction to the herbal medication milk thistle (Silybum marianum). Adverse Drug Reactions Advisory Committee

26 September 2018

1 reference

12 December 2020

A pilot study on the liver protective effect of silybin-phosphatidylcholine complex (IdB1016) in chronic active hepatitis

1 reference

12 December 2020

Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis

1 reference

12 December 2020

A case of urticaria during carsil treatment

1 reference

12 December 2020

Silymarin in pregnancy and during hormonal contraceptive treatment. Blood chemistry and ultrastructural findings in the experimental model

1 reference

12 December 2020

A review of plants used in the treatment of liver disease: part 1

1 reference

12 December 2020

Serum YKL-40 is increased in patients with hepatic fibrosis

1 reference

12 December 2020

Effect of silymarin on chemical, functional, and morphological alterations of the liver. A double-blind controlled study

1 reference

12 December 2020

Scavenging of reactive oxygen species by silibinin dihemisuccinate

1 reference

12 December 2020

Identifiers

PMC publication ID

3214335

1 reference

8 August 2017

1 reference